Provided by Tiger Fintech (Singapore) Pte. Ltd.

LUCID DIAGNOSTICS INC.

1.39
+0.11008.59%
Post-market: 1.420.0287+2.06%19:59 EDT
Volume:1.22M
Turnover:1.70M
Market Cap:101.86M
PE:-1.24
High:1.46
Open:1.31
Low:1.29
Close:1.28
Loading ...

Lucid Diagnostics’ Strategic Financial Maneuvering and Agreements

TIPRANKS
·
30 Nov 2024

Lucid Diagnostics submits clinical evidence for EsoGuard Esophagea DNA test

TIPRANKS
·
20 Nov 2024

Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test

PR Newswire
·
20 Nov 2024

Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

PR Newswire
·
18 Nov 2024

PAVmed Inc (PAVM) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Restructuring

GuruFocus.com
·
15 Nov 2024

PAVmed: Ongoing Initiatives Position PAVmed to Preserve Nasdaq Listing

THOMSON REUTERS
·
14 Nov 2024

PAVmed Inc: Qtrly Shr Loss $0.54

THOMSON REUTERS
·
14 Nov 2024

PAVmed Provides Business Update and Third Quarter 2024 Financial Results

PR Newswire
·
14 Nov 2024

Lucid Diagnostics Price Target Maintained With a $2.50/Share by Needham

Dow Jones
·
14 Nov 2024

Lucid Diagnostics Inc (LUCD) Q3 2024 Earnings Call Highlights: Record Revenue Growth Amid ...

GuruFocus.com
·
14 Nov 2024

Lucid Diagnostics Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
13 Nov 2024

Lucid Diagnostics Provides Business Update and Third Quarter 2024 Financial Results

THOMSON REUTERS
·
13 Nov 2024

Press Release: Lucid Diagnostics Provides Business Update and Third Quarter 2024 Financial Results

Dow Jones
·
13 Nov 2024

Lucid Diagnostics Q3 2024 GAAP EPS $(0.25) Misses $(0.22) Estimate, Sales $1.17M Beat $1.14M Estimate

Benzinga
·
13 Nov 2024

Lucid Diagnostics Inc expected to post a loss of 22 cents a share - Earnings Preview

Reuters
·
11 Nov 2024

BRIEF-Lucid Diagnostics' Esoguard BE-1 Prospective Multicenter Clinical Validation Study Of Esoguard Esophageal Precancer Testing Accepted For Peer-Reviewed Publication

Reuters
·
07 Nov 2024